In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195

E Rissanen, J Tuisku, J Rokka… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Patients with secondary progressive multiple sclerosis (SPMS) are lacking efficient
medication to slow down the progression of their disease. PET imaging holds promise as a …

[HTML][HTML] Imaging neuroinflammation in multiple sclerosis using TSPO-PET

L Airas, E Rissanen, JO Rinne - Clinical and translational imaging, 2015 - Springer
Conventional MR imaging (MRI) techniques form the cornerstone of multiple sclerosis (MS)
diagnostics and clinical follow-up today. MRI is sensitive in demonstrating focal inflammatory …

TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis

M Unterrainer, C Mahler, L Vomacka, S Lindner… - European journal of …, 2018 - Springer
Purpose Expression of the translocator protein (TSPO) is upregulated in activated
macrophages/microglia and is considered to be a marker of neuroinflammation. We …

[HTML][HTML] TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis

L Vomacka, NL Albert, S Lindner, M Unterrainer… - EJNMMI research, 2017 - Springer
Background PET ligands targeting the translocator protein (TSPO) represent promising tools
to visualise neuroinflammation. Here, we analysed parameters obtained in dynamic and …

[HTML][HTML] In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

A Takano, F Piehl, J Hillert, A Varrone, S Nag… - EJNMMI research, 2013 - Springer
Background The activation of microglia, in general, and the upregulation of the translocator
protein (18 kDa)(TSPO) system, in particular, are key features of neuroinflammation, of …

11C-PBR28 and 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis

G Datta, A Colasanti, N Kalk, D Owen… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The objective of this study was to assess microglial activation in lesions and in normal-
appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET. Methods …

Translocator protein PET imaging for glial activation in multiple sclerosis

U Oh, M Fujita, VN Ikonomidou, IE Evangelou… - Journal of neuroimmune …, 2011 - Springer
Glial activation in the setting of central nervous system inflammation is a key feature of the
multiple sclerosis (MS) pathology. Monitoring glial activation in subjects with MS, therefore …

In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET

A Colasanti, Q Guo, N Muhlert, P Giannetti… - Journal of Nuclear …, 2014 - Soc Nuclear Med
PET radioligand binding to the 18-kD translocator protein (TSPO) in the brains of patients
with multiple sclerosis (MS) primarily reflects activated microglia and macrophages. We …

[HTML][HTML] Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography

L Airas, M Nylund, E Rissanen - Frontiers in Neurology, 2018 - frontiersin.org
Understanding the mechanisms underlying progression in multiple sclerosis (MS) is one of
the key elements contributing to the identification of appropriate therapeutic targets for this …

[HTML][HTML] In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET

MHJ Hagens, SV Golla, MT Wijburg, M Yaqub… - Journal of …, 2018 - Springer
Background Over the past decades, positron emission tomography (PET) imaging has
become an increasingly useful research modality in the field of multiple sclerosis (MS) …